• Phenobarbital, Serum
  • Troponin-I/T, Cardiac
  • Brompheniramine
  • Vitamin B12 Absorption (Schilling) Test
  • Phenosense HIV Drug Resistance Replication Capacity
  • Calcium, Ionized
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • Aspergillus fumigatus Antibody, IgG
  • RBC Band 3 Protein Reduction in Hereditary Spherocytosis
  • Creatine Kinase MB (CKMB)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Overview
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.